Is Your Lab Ready?

Watch Video

Solving the world's most pressing challenges

Battelle is a major force in science and technology discovery and in the translation of knowledge into innovative solutions.

Battelle makes the world safer, healthier and more productive.

researcher working in a lab
Forensic Genomics
Battelle's Massively Parallel Sequencing (MPS) capabilities (also known as Next Generation Sequencing) enable more precise identification and characterization of humans, microbes, plants and animals. Learn More
graphic showing white paper teaser
Moving MPS to the Mainstream
Massively Parallel Sequencing (MPS) technology has been previously used primarily in research environments, but a growing number of DNA forensic labs are in the process of validating the technology. In this white paper, Battelle offers an implementation roadmap for MPS in forensic labs. Download
NIJ Research Study Webinar - Overview of the Testing Results for the Massively Parallel Sequencing (MPS) Feasibility and Guidance Study for Forensic DNA
NIJ Study on MPS Webinar
The National Institute of Justice awarded Battelle a 19-month applied research project to evaluate the feasibility of Massively Parallel Sequencing (MPS) technology for forensic science applications. This webinar discusses the results of the study and provides an objective assessment of MPS technologies. Attend
graphic representation of DNA
Battelle ExactID®
ExactID ushers in the new era of investigative genetics. Our proprietary ExactID software allows you to exploit the full power of Massively Parallel Sequencing (MPS) technologies to find new leads in genetic data that was previously considered unusable. Learn More
test tubes in a lab
Identifying drug resistance of microbial pathogens is critical to productive analysis of infectious disease in biosurveillance applications. Battelle’s proprietary software, CRITERIOME, analyzes genomic sequence data to rapidly and accurately identify microbes and to predict potential drug susceptibility/resistance profiles. Learn More